文献速递肿瘤 PET/CT放射性药物与辐射防护

人工智能引导的数字PET增强:扫描速度可如CT?

Artificial intelligence guided enhancement of digital PET: scans as fast as CT?
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2022-07-29

这是一项前瞻性单臂单中心I/II期影像研究,共纳入587例患者,在数字PET/CT上采集全身约30秒的超低计数FDG ExtremePET图像,并用改进的pix2pixHD深度学习网络生成合成全剂量PET图像。含分组卷积的PET/CT输入模型在病灶信号恢复方面表现最佳,合成图像视觉质量高,病灶SUVmax平均绝对差为1.5,患者水平病灶检测灵敏度和特异度分别为79%和100%。

要点

  • 含分组卷积的PET/CT输入模型在病灶信号恢复方面表现最佳并被选作详细评估。
  • 合成PET图像视觉质量高,病灶SUVmax平均绝对差为1.5。
  • 患者水平病灶检测灵敏度79%、特异度100%,未检出病灶的示踪剂摄取和病灶体积较低。

核心结论

  • 在极快采集时间背景下,病灶可检测性和病灶定量结果具有前景。
  • 可能的应用场景包括晚期癌症患者的再分期,此类患者评估总肿瘤负荷可能比详细评估小而低摄取病灶更具相关性。

研究设计与样本

  • 前瞻性、单臂、单中心I/II期影像研究,共纳入587例患者。
  • 每例患者均采集标准FDG PET/CT和超低计数FDG PET/CT(全身采集时间约30秒)。
  • 采用改进的pix2pixHD深度学习网络,以387个数据集为训练集、200个为测试集。
  • 比较三种模型:仅PET、PET/CT以及含或不含分组卷积的PET/CT。

主要发现

  • 含分组卷积的PET/CT输入模型在病灶信号恢复方面表现最佳,并被选作详细评估。
  • 合成PET图像视觉图像质量高;病灶SUVmax平均绝对差为1.5。
  • 患者水平病灶检测灵敏度为79%,特异度为100%。
  • 未检测到的病灶示踪剂摄取较低且病灶体积较小。
  • 在配对比较中,患者水平(病灶水平)检出率对PERCIST可测量病灶为89%(78%),对非PERCIST可测量病灶为36%(22%)。

关键数值与推荐

  • 患者水平病灶检测灵敏度79%、特异度100%。
  • 病灶SUVmax平均绝对差为1.5。
  • 患者水平(病灶水平)检出率:PERCIST可测量病灶89%(78%),非PERCIST可测量病灶36%(22%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Both digital positron emission tomography (PET) detector technologies and artificial intelligence based image post-reconstruction methods allow to reduce the PET acquisition time while maintaining diagnostic quality. The aim of this study was to acquire ultra-low-count fluorodeoxyglucose (FDG) ExtremePET images on a digital PET/computed tomography (CT) scanner at an acquisition time comparable to a CT scan and to generate synthetic full-dose PET images using an artificial neural network. METHODS: This is a prospective, single-arm, single-center phase I/II imaging study. A total of 587 patients were included. For each patient, a standard and an ultra-low-count FDG PET/CT scan (whole-body acquisition time about 30 s) were acquired. A modified pix2pixHD deep-learning network was trained employing 387 data sets as training and 200 as test cohort. Three models (PET-only and PET/CT with or without group convolution) were compared. Detectability and quantification were evaluated. RESULTS: The PET/CT input model with group convolution performed best regarding lesion signal recovery and was selected for detailed evaluation. Synthetic PET images were of high visual image quality; mean absolute lesion SUVmax (maximum standardized uptake value) difference was 1.5. Patient-based sensitivity and specificity for lesion detection were 79% and 100%, respectively. Not-detected lesions were of lower tracer uptake and lesion volume. In a matched-pair comparison, patient-based (lesion-based) detection rate was 89% (78%) for PERCIST (PET response criteria in solid tumors)-measurable and 36% (22%) for non PERCIST-measurable lesions. CONCLUSION: Lesion detectability and lesion quantification were promising in the context of extremely fast acquisition times. Possible application scenarios might include re-staging of late-stage cancer patients, in whom assessment of total tumor burden can be of higher relevance than detailed evaluation of small and low-uptake lesions.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Hosch R, Weber M, Sraieb M, et al. Artificial intelligence guided enhancement of digital PET: scans as fast as CT? Eur J Nucl Med Mol Imaging. 2022. PMID: 35904589. doi:10.1007/s00259-022-05901-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。